Baudax Bio Total Liabilities

Baudax Bio (BXRX) currently reports a total liabilities of $31M as of September 2023. That compares with $37M in the prior-year period — down 16.8% year over year. Use the charts on this page to explore Baudax Bio's total liabilities history and peer comparisons.

Baudax Bio's total liabilities decreased from $37M to $31M — a 16.8% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Baudax Bio reported $31M in total liabilities as of September 2023. That compares with $37M in the prior-year period — down 16.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $31M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Baudax Bio, and consider following BXRX for alerts when major investors trade the stock.

Baudax Bio is classified in the Healthcare sector. On total liabilities, it currently shows $31M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BXRX with unrelated industries.